133 related articles for article (PubMed ID: 37190241)
1. MRI-Based Tumor Necrosis Depiction in Pancreatic Ductal Adenocarcinoma: Can It Predict Tumor Aggressiveness?
Anderson MA; Knipp DE; Noda Y; Kamran SC; Baliyan V; Kordbacheh H; Hong TS; Kambadakone A
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190241
[TBL] [Abstract][Full Text] [Related]
2. Abbreviated Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Adenocarcinoma.
Yamaguchi T; Sofue K; Ueshima E; Ueno Y; Tsujita Y; Yabe S; Shirakawa S; Toyama H; Hori M; Fukumoto T; Murakami T
J Magn Reson Imaging; 2022 Sep; 56(3):725-736. PubMed ID: 35005813
[TBL] [Abstract][Full Text] [Related]
3. Identification of intratumoral fluid-containing area by magnetic resonance imaging to predict prognosis in patients with pancreatic ductal adenocarcinoma after curative resection.
Kim H; Kim DH; Song IH; Youn SY; Kim B; Oh SN; Choi JI; Rha SE
Eur Radiol; 2022 Apr; 32(4):2518-2528. PubMed ID: 34671833
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
[TBL] [Abstract][Full Text] [Related]
6. Survival Prediction after Curative Resection of Pancreatic Ductal Adenocarcinoma by Imaging-Based Intratumoral Necrosis.
Kim H; Kim DH; Song IH; Kim B; Oh SN; Choi JI; Rha SE
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428764
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Imaging Radiomics-Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study.
Shi Z; Ma C; Huang X; Cao D
J Magn Reson Imaging; 2022 Mar; 55(3):823-839. PubMed ID: 34997795
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted and dynamic contrast-enhanced MRI of pancreatic adenocarcinoma xenografts: associations with tumor differentiation and collagen content.
Wegner CS; Gaustad JV; Andersen LM; Simonsen TG; Rofstad EK
J Transl Med; 2016 Jun; 14(1):161. PubMed ID: 27268062
[TBL] [Abstract][Full Text] [Related]
9. Adding Delayed Phase Images to Dual-Phase Contrast-Enhanced CT Increases Sensitivity for Small Pancreatic Ductal Adenocarcinoma.
Fukukura Y; Kumagae Y; Fujisaki Y; Yamagishi R; Nakamura S; Kamizono J; Nakajo M; Kamimura K; Nagano H; Takumi K; Yoshiura T
AJR Am J Roentgenol; 2021 Oct; 217(4):888-897. PubMed ID: 33759561
[No Abstract] [Full Text] [Related]
10. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
[TBL] [Abstract][Full Text] [Related]
11. Correlation of MR features and histogram-derived parameters with aggressiveness and outcomes after resection in pancreatic ductal adenocarcinoma.
De Robertis R; Beleù A; Cardobi N; Frigerio I; Ortolani S; Gobbo S; Maris B; Melisi D; Montemezzi S; D'Onofrio M
Abdom Radiol (NY); 2020 Nov; 45(11):3809-3818. PubMed ID: 32266504
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens.
Ma C; Yang P; Li J; Bian Y; Wang L; Lu J
Abdom Radiol (NY); 2020 Mar; 45(3):782-788. PubMed ID: 31292672
[TBL] [Abstract][Full Text] [Related]
13. Radiomics models based on multi-sequence MRI for preoperative evaluation of MUC4 status in pancreatic ductal adenocarcinoma: a preliminary study.
Deng Y; Li Y; Wu JL; Zhou T; Tang MY; Chen Y; Zuo HD; Tang W; Chen TW; Zhang XM
Quant Imaging Med Surg; 2022 Nov; 12(11):5129-5139. PubMed ID: 36330180
[TBL] [Abstract][Full Text] [Related]
14. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
Jia H; Li J; Huang W; Lin G
BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
[TBL] [Abstract][Full Text] [Related]
15. Use of ring-enhancement and focal necrosis to differentiate pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma on CT and MRI.
Schawkat K; Tsai LL; Jaramillo-Cardoso A; Paez SN; Moser JA; Decicco C; Singer T; Glickman J; Brook A; Manning MA; Mortele KJ
Clin Imaging; 2021 May; 73():134-138. PubMed ID: 33387918
[TBL] [Abstract][Full Text] [Related]
16. Non-contrast-enhanced CT texture analysis of primary and metastatic pancreatic ductal adenocarcinomas: value in assessment of histopathological grade and differences between primary and metastatic lesions.
Janisch M; Adelsmayr G; Müller H; Holzinger A; Janek E; Talakic E; Fuchsjäger M; Schöllnast H
Abdom Radiol (NY); 2022 Dec; 47(12):4151-4159. PubMed ID: 36104481
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a multi-parameters MRI model for predicting small lymph nodes metastases (<10 mm) in patients with resected pancreatic ductal adenocarcinoma.
Shi YJ; Liu BN; Li XT; Zhu HT; Wei YY; Zhao B; Sun SS; Sun YS; Hao CY
Abdom Radiol (NY); 2022 Sep; 47(9):3217-3228. PubMed ID: 34800159
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer.
Kang JH; Lee SS; Kim JH; Byun JH; Kim HJ; Yoo C; Kim KP; Ryoo BY; Kim SC
Eur Radiol; 2021 Feb; 31(2):864-874. PubMed ID: 32813104
[TBL] [Abstract][Full Text] [Related]
19. Non-enhanced magnetic resonance imaging-based radiomics model for the differentiation of pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma.
Li Q; Li X; Liu W; Yu J; Chen Y; Zhu M; Li N; Liu F; Wang T; Fang X; Li J; Lu J; Shao C; Bian Y
Front Oncol; 2023; 13():1108545. PubMed ID: 36756153
[TBL] [Abstract][Full Text] [Related]
20. MRI of pancreatic ductal adenocarcinoma: texture analysis of T2-weighted images for predicting long-term outcome.
Choi MH; Lee YJ; Yoon SB; Choi JI; Jung SE; Rha SE
Abdom Radiol (NY); 2019 Jan; 44(1):122-130. PubMed ID: 29980829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
